Top

BMC Health Services Research

Published in:

Open Access 01-12-2015 | Research article

Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study

Authors: Chuanlin Li, Leiyu Shi, Jiayan Huang, Xu Qian, Yingyao Chen

Published in: BMC Health Services Research | Issue 1/2016

Abstract

Background

Knowledge of the factors that influence maternal serum screening (MSS) service utilization can be used to develop health policies to promote equitable access to MSS and further diagnostic tests. The purpose of this study was to find the factors associated with utilization of MSS as well as the current status of service utilization in mainland China.

Methods

This was a hospital-based cross-sectional study with respondents interviewed with a questionnaire designed based on Andersen’s behavioral model. Descriptive statistics, univariate analysis, and multilevel logistic regression analysis were used to identify the factors associated with MSS utilization, and to explore potential methods to improve screening uptake.

Results

A total of 8110 women who had given birth within the previous 7 days in one of 111 participating institutions from six provinces in mainland China were interviewed. Approximately 36 % of the participants had used MSS. Women between 20 and 35 years, who resided in urban areas, were educated, were in a stable occupation, who had health knowledge, who attended maternal preparation classes, who had received eight or more prenatal checkups, who were from a region of higher social economic status, and who delivered in a tertiary healthcare institution were significantly more likely to use MSS than their counterparts. As compared with other factors, insufficient education is the single most important demographic factor for service underutilization.

Conclusions

Efforts should not only be made to target the population that underuses MSS, but the overall organization of MSS service delivery should be assessed during policy development to make access to MSS equitable to the entire population of mainland China.

Ministry of Health of People’s Republic of China. Report on birth defects prevention and treatment of PRC (2012). Beijing: Ministry of Health of People’s Republic of China; 2012. [Chinese]

Chen YY, Qian X, Zhang J, et al. Preliminary study into the economic burden of Down syndrome in China. Birth Defects Res A Clin Mol Teratol. 2008;82(1):25–33.PubMedCrossRef

Bian XM, Qi QW. Future perception of prenatal screening and diagnostic service of chromosomal abnormal. Chinese practical gynecology and obstetrics. 2010;26:889–91 [Chinese].

Huang SZ. The experience of prenatal diagnosis in China, Prenatal diagnosis – Morphology scan and invasive methods, Dr. Richard Choy (Ed.), ISBN:978953-51-0614-2, In tech, Available from: http://cdn.intechopen.com/pdfs-wm/37629.pdf.

Andersen R, Rice T, Kominski R. Changing the U.S. Health care system: Key issues in health services policy and management. San Francisco: Jossey-Bass; 2001. p. 4–5.

Center for Health Statistics and Information of MOH. An Analysis Report of National Health Services Survey in China (2008). http://www.moh.gov.cn/mohwsbwstjxxzx/s8211/201009/49165.shtml. Accessed 20 Oct 2014. [Chinese]

Skirton H, Barr O. Influences on uptake of antenatal screening for Down syndrome: a review of the literature. Evidence Based Midwifery. 2007, March. https://www.rcm.org.uk/learning-and-career/learning-and-research/ebm-articles/influences-on-uptake-of-antenatal-screening. Accessed 31 Dec 2014

Lindstrom DP, Muñoz-Franco E. Migration and maternal health services utilization in rural Guatemala. Soc Sci Med. 2006;63(3):706–21.PubMedCrossRef

Dormandy E, Michie S, Hooper R, et al. Low uptake of prenatal screening for Down syndrome in minority ethnic groups and socially deprived groups: a reflection of women's attitudes or a failure to facilitate informed choices? J Matern Fetal Neonatal Med. 2013;26(17):1676–81.CrossRef

10.

Fuchs KM, Peipert JF. First trimester Down syndrome screening: public health implications. Semin Perinatol. 2005;29(4):267–71.PubMedCrossRef

11.

Rowe RE, Garcia J, Davidson LL. Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK: a systematic review. Public Health. 2004;118(3):177–89.PubMedCrossRef

12.

Press N, Browner CH. Why women say yes to prenatal diagnosis. Soc Sci Med. 1997;45(7):979–89.PubMedCrossRef

13.

der Wal JT G-v, Verhoeven PS, Manniën J. Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study. BMC Pregnancy Childbirth. 2014;14:264.CrossRef

14.

Crombag NM, Schielen PC, Hukkelhoven CW, Iedema R, Bensing JM, Visser GH, et al. Determinants of first trimester combined test participation within the central region of the Netherlands. Prenat Diagn. 2015;35(5):486–92.PubMedCrossRef

15.

Vassy C, Rosman S, Rousseau B. From policy making to service use. Down's syndrome antenatal screening in England, France and the Netherlands. Soc Sci Med. 2014;106:67–74.PubMedCrossRef

16.

Shantha N, Granger K, Arora P, Polson D. Women's choice for Down's screening--a comparative experience in three district general hospitals. Eur J Obstet Gynecol Reprod Biol. 2009;146(1):61–4.PubMedCrossRef

17.

Lo TK, Lai FK, Leung WC, Lau WL, Tang LC, Chin RK. A new policy for prenatal screening and diagnosis of Down syndrome for pregnant women with advanced maternal age in a public hospital. J Matern Fetal Neonatal Med. 2010;23(8):914–9.PubMedCrossRef

18.

Engels MA, Bhola SL, Twisk JW, Blankenstein MA, van Vugt JM. Evaluation of the introduction of the national Down syndrome screening program in the Netherlands: age-related uptake of prenatal screening and invasive diagnostic testing. Eur J Obstet Gynecol Reprod Biol. 2014;174:59–63.PubMedCrossRef

19.

Crombag NM, Vellinga YE, Kluijfhout SA, Bryant LD, Ward PA, Iedema-Kuiper R, et al. Explaining variation in Down’s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res. 2014;14:437.PubMedPubMedCentralCrossRef

20.

Karen Eggleston. Health Care for 1.3 Billion: An Overview of China’s Health System. Asia Health Policy Program working paper # 28.2012. http://iis-db.stanford.edu/pubs/23668/AHPPwp_28.pdf. Accessed 14 Nov 2014.

21.

Ministry of Statistics of PRC. Statistic year book of 2007 of China. Bejing: The Statistics Press of China; 2007. [Chinese]

22.

Irving C, Basu A, Richmond S, Burn J, Wren C. Twenty-year trends in prevalence and survival of Down syndrome. Eur J Hum Genet. 2008;16(11):1336–40.PubMedCrossRef

23.

Zehrer T, Stankeviciene I, Abdel-Aal M. Comparison of National Downs screening uptake, results, and outcomes to a district general hospital. https://fetalmedicine.org/abstracts/2014/abstracts/259.pdf. Accessed 31 Dec 2014.

24.

O'Leary P, Breheny N, Reid G, Charles T, Emery J. Regional variations in prenatal screening across Australia: stepping towards a national policy framework. Aust N Z J Obstet Gynaecol. 2006;46:427–32.PubMedCrossRef

25.

Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE. Screening for down syndrome in the United States: results of surveys in 2011 and 2012. Arch Pathol Lab Med. 2013;137(7):921–6.PubMedCrossRef

26.

Ekelund CK, Jørgensen FS, Petersen OB, Sundberg K, Tabor A, Danish Fetal Medicine Research Group. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ. 2008;337:a2547.PubMedPubMedCentralCrossRef

27.

Fang YM, Benn P, Campbell W. Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists. Am J Obstet Gynecol. 2009;201:97. e1-5.PubMedCrossRef

28.

Norton ME, Norem C, Nakagawa S, Gregorich S, Kuppermann M. Effect of changes in prenatal screening and diagnostic testing policies on resources utilization in a large, integrated health care system. Am J Obstet Gynecol. 2012;206:S317.CrossRef

29.

Sebastian L, Steven W, Letty R, Malgorzata M, David P, Alfred A. Combined first trimester screen use in high and low risk patient populations after noninvasive prenatal testing. Am J Obstet Gynecol. 2015;212:S415.

30.

Hayeems RZ, Campitelli M, Ma X, Huang T, Walker M, Guttmann A. Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study. CMAJ Open. 2015;3(2):E236–43.PubMedPubMedCentralCrossRef

31.

Harris R, Lane B, Harris H, Williamson P, Dodge J, Modell B, et al. National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care. Br J Obstet Gyaecol. 1999;106:658–63.CrossRef

32.

Huang J, Chen Y, Pong RW. Factors influencing prenatal screening for Down's syndrome: evidence from Zhejiang (china). Asia Pac J Public Health. 2015;27(2):1288–97.CrossRef

33.

Fransen MP, Essink-Bot ML, Oenema A, Mackenbach JP, Steegers EA, Wildschut HI. Ethnic differences in determinants of participation and non-participation in prenatal screening for down-syndrome: a theoretical framework. Prenat Diagn. 2007;27:938–50.PubMedCrossRef

34.

Maxwell S, Brameld K, Bower C, Dickinson JE, Goldblatt J, Hadlow N, et al. Socio-demographic disparities in the uptake of prenatal screening and diagnosis in Western Australia. Aust N Z J Obstet Gynaecol. 2011;51:9–16.PubMedCrossRef

35.

Tischler R, Hudgins L, Blumenfeld YJ, Greely HT, Ormond KE. Noninvasive prenatal diagnosis: pregnant women’s interest and expected uptake. Prenat Diagn. 2011;31:1292–9.PubMedPubMedCentralCrossRef

36.

Yu JA. Systematic review of issues around antenatal screening and prenatal diagnostic testing for genetic disorders: women of Asian origin in western countries. Health Soc Care Community. 2012;20:329–46.PubMedCrossRef

37.

Fransen MH, de Koning HJ, Lausy JA, Fransen MP, Schoonen MH, Mackenbach JP, et al. Ethnic differences in participation in prenatal screening for Down syndrome: a register-based study. Prenat Diagn. 2010;30:988–94.PubMedCrossRef

38.

McNeill J, Alderdice F, Rowe R, Martin D. Down’s syndrome screening in Northern Ireland: women’s reasons for accepting or declining serum testing. Evidence Based Midwifery. 2009;7(3):76–83.

39.

Crombag NM, Bensing JM, Iedema-Kuiper R, Schielen PC, Visser GH. Determinants affecting pregnant women's utilization of prenatal screening for Down syndrome: a review of the literature. J Matern Fetal Neonatal Med. 2013;26(17):1676–81.PubMedCrossRef

40.

Godino L, Turchetti D, Skirton H. A systematic review of factors influencing uptake of invasive fetal genetic testing by pregnant women of advanced maternal age. Midwifery. 2013;29(11):1235–43.PubMedCrossRef

41.

Boyd PA, DeVigan C, Khoshnood B, Loane M, Garne E, Dolk H, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndrome. BJOG. 2008;115(6):689–96.PubMedPubMedCentralCrossRef

42.

Verweij EJ, Veersema D, Pajkrt E, Haak MC. Decision making in prenatal screening: money matters. Acta Obstet Gynecol Scand. 2015;94(2):212–4.PubMedCrossRef

Title: Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study
Authors: Chuanlin Li
Leiyu Shi
Jiayan Huang
Xu Qian
Yingyao Chen
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI: https://doi.org/10.1186/s12913-016-1260-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Assessing the disparity in spatial access to hospital care in ethnic minority region in Sichuan Province, China

End of life hospitalisations differ for older Australian women according to death trajectory: a longitudinal data linkage study

Improving prevention and care for HIV and sexually transmitted infections among men who have sex with men in Cambodia: the sustainable action against HIV and AIDS in communities (SAHACOM)

Emergency Department and Inpatient Healthcare utilization due to Hypertension

Differences in nulliparous caesarean section rates across models of care: a decomposition analysis

Stakeholders’ perceptions of ways to support decisions about health insurance marketplace enrollment: a qualitative study